The U.S. Food and Drug Administration (FDA) approved suzetrigine under the brand name Journavx on Jan. 30, 2025. Journavx is a first-in-class non-opioid painkiller that acts on sodium channels in the ...
UPS stock tumbled on Thursday as investors digested a weaker-than-expected sales forecast as the company scales back its business with Amazon. Yahoo Finance will chronicle the latest news and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback